Industry Research Reports
Home > Reports > Chemical & Material > Global Trans-β-farnesene Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Trans-β-farnesene Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-08-05
Pages: 120 Pages
Report ld: 4852680
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Trans-β-farnesene Market Size(US$)
CAGR 2025-2031
4.7%
Market Size,2031
USD 104
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 79.1 million
Market Forecast in 2031(Value)
US$ 104 million
CAGR
4.7%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Trans-β-farnesene market is projected to grow from US$ 75.9 million in 2024 to US$ 104 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Trans-β-farnesene is capable of being polymerized by both anionic and cationic pathways, creating low molecular weight polymers with structure–property relationships unique within the diene class of monomers. Trans-β-farnesene is produced through fermentation of sugar feedstocks. The pathway offers an alternative to petroleum-based feedstocks derived as by-products of naphtha or ethane cracking. Anionic polymerization of the monomer produces a highly branched “bottlebrush” structure, with rheological properties that are markedly different than those of linear diene polymers. Specifically, a lack of entanglements is observed even at relatively high molar masses. For hydroxyl-terminated oligomers, Tg as a function of molar mass follows a trend opposite non-functional materials.
From a downstream perspective, Polymers & Adhesives accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Trans-β-farnesene leading manufacturers including Amyris, Cayman Chemical, Santa Cruz Biotechnology, Hesheng Tech, Taskcm, etc., dominate supply; the top five capture approximately % of global revenue, with Amyris leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Trans-β-farnesene market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Amyris
- Cayman Chemical
- Santa Cruz Biotechnology
- Hesheng Tech
- Taskcm
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Anionic Pathways
- Cationic Pathways
Segment by Application
- Polymers & Adhesives
- Tires & LFR
- Cosmetics
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Trans-β-farnesene study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Trans-β-farnesene: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Trans-β-farnesene Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Anionic Pathways
1.2.3 Cationic Pathways
1.3 Market Segmentation by Application
1.3.1 Global Trans-β-farnesene Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Polymers & Adhesives
1.3.3 Tires & LFR
1.3.4 Cosmetics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Trans-β-farnesene Revenue Estimates and Forecasts 2020-2031
2.2 Global Trans-β-farnesene Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Trans-β-farnesene Sales Estimates and Forecasts 2020-2031
2.4 Global Trans-β-farnesene Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Trans-β-farnesene Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Trans-β-farnesene Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Trans-β-farnesene Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Anionic Pathways Market Size by Manufacturers
4.5.2 Cationic Pathways Market Size by Manufacturers
4.6 Global Trans-β-farnesene Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Trans-β-farnesene Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Trans-β-farnesene Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Trans-β-farnesene Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Trans-β-farnesene Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Trans-β-farnesene Sales and Revenue by Type (2020-2031)
7.4 North America Trans-β-farnesene Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Trans-β-farnesene Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Trans-β-farnesene Sales and Revenue by Type (2020-2031)
8.4 Europe Trans-β-farnesene Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Trans-β-farnesene Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Trans-β-farnesene Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Trans-β-farnesene Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Trans-β-farnesene Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Trans-β-farnesene Sales and Revenue by Type (2020-2031)
10.4 Central and South America Trans-β-farnesene Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Trans-β-farnesene Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Trans-β-farnesene Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Trans-β-farnesene Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Trans-β-farnesene Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Amyris
12.1.1 Amyris Corporation Information
12.1.2 Amyris Business Overview
12.1.3 Amyris Trans-β-farnesene Product Models, Descriptions and Specifications
12.1.4 Amyris Trans-β-farnesene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Amyris Trans-β-farnesene Sales by Product in 2024
12.1.6 Amyris Trans-β-farnesene Sales by Application in 2024
12.1.7 Amyris Trans-β-farnesene Sales by Geographic Area in 2024
12.1.8 Amyris Trans-β-farnesene SWOT Analysis
12.1.9 Amyris Recent Developments
12.2 Cayman Chemical
12.2.1 Cayman Chemical Corporation Information
12.2.2 Cayman Chemical Business Overview
12.2.3 Cayman Chemical Trans-β-farnesene Product Models, Descriptions and Specifications
12.2.4 Cayman Chemical Trans-β-farnesene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Cayman Chemical Trans-β-farnesene Sales by Product in 2024
12.2.6 Cayman Chemical Trans-β-farnesene Sales by Application in 2024
12.2.7 Cayman Chemical Trans-β-farnesene Sales by Geographic Area in 2024
12.2.8 Cayman Chemical Trans-β-farnesene SWOT Analysis
12.2.9 Cayman Chemical Recent Developments
12.3 Santa Cruz Biotechnology
12.3.1 Santa Cruz Biotechnology Corporation Information
12.3.2 Santa Cruz Biotechnology Business Overview
12.3.3 Santa Cruz Biotechnology Trans-β-farnesene Product Models, Descriptions and Specifications
12.3.4 Santa Cruz Biotechnology Trans-β-farnesene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Santa Cruz Biotechnology Trans-β-farnesene Sales by Product in 2024
12.3.6 Santa Cruz Biotechnology Trans-β-farnesene Sales by Application in 2024
12.3.7 Santa Cruz Biotechnology Trans-β-farnesene Sales by Geographic Area in 2024
12.3.8 Santa Cruz Biotechnology Trans-β-farnesene SWOT Analysis
12.3.9 Santa Cruz Biotechnology Recent Developments
12.4 Hesheng Tech
12.4.1 Hesheng Tech Corporation Information
12.4.2 Hesheng Tech Business Overview
12.4.3 Hesheng Tech Trans-β-farnesene Product Models, Descriptions and Specifications
12.4.4 Hesheng Tech Trans-β-farnesene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Hesheng Tech Trans-β-farnesene Sales by Product in 2024
12.4.6 Hesheng Tech Trans-β-farnesene Sales by Application in 2024
12.4.7 Hesheng Tech Trans-β-farnesene Sales by Geographic Area in 2024
12.4.8 Hesheng Tech Trans-β-farnesene SWOT Analysis
12.4.9 Hesheng Tech Recent Developments
12.5 Taskcm
12.5.1 Taskcm Corporation Information
12.5.2 Taskcm Business Overview
12.5.3 Taskcm Trans-β-farnesene Product Models, Descriptions and Specifications
12.5.4 Taskcm Trans-β-farnesene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Taskcm Trans-β-farnesene Sales by Product in 2024
12.5.6 Taskcm Trans-β-farnesene Sales by Application in 2024
12.5.7 Taskcm Trans-β-farnesene Sales by Geographic Area in 2024
12.5.8 Taskcm Trans-β-farnesene SWOT Analysis
12.5.9 Taskcm Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Trans-β-farnesene Industry Chain
13.2 Trans-β-farnesene Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Trans-β-farnesene Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Trans-β-farnesene Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Trans-β-farnesene Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Trans-β-farnesene Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Trans-β-farnesene Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Trans-β-farnesene Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Trans-β-farnesene Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Trans-β-farnesene Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Trans-β-farnesene Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Trans-β-farnesene Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Trans-β-farnesene Sales by Region (2020-2025) & (Tons)
Table 8. Global Trans-β-farnesene Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Trans-β-farnesene Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Trans-β-farnesene Production by Region (2020-2025) & (Tons)
Table 12. Global Trans-β-farnesene Production by Region (2026-2031) & (Tons)
Table 13. Global Trans-β-farnesene Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Trans-β-farnesene Sales Share by Manufacturers (2020-2025)
Table 15. Global Trans-β-farnesene Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Trans-β-farnesene Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Trans-β-farnesene by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trans-β-farnesene as of 2024)
Table 19. Global Trans-β-farnesene Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Trans-β-farnesene Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Trans-β-farnesene Manufacturing Base and Headquarters
Table 22. Global Trans-β-farnesene Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Trans-β-farnesene Sales by Type (2020-2025) & (Tons)
Table 26. Global Trans-β-farnesene Sales by Type (2026-2031) & (Tons)
Table 27. Global Trans-β-farnesene Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Trans-β-farnesene Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Trans-β-farnesene ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Trans-β-farnesene Sales by Application (2020-2025) & (Tons)
Table 32. Global Trans-β-farnesene Sales by Application (2026-2031) & (Tons)
Table 33. Trans-β-farnesene High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Trans-β-farnesene Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Trans-β-farnesene Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Trans-β-farnesene ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Trans-β-farnesene Growth Accelerators and Market Barriers
Table 40. North America Trans-β-farnesene Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Trans-β-farnesene Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Trans-β-farnesene Growth Accelerators and Market Barriers
Table 43. Europe Trans-β-farnesene Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Trans-β-farnesene Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Trans-β-farnesene Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Trans-β-farnesene Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Trans-β-farnesene Growth Accelerators and Market Barriers
Table 48. Southeast Asia Trans-β-farnesene Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Trans-β-farnesene Investment Opportunities and Key Challenges
Table 50. Central and South America Trans-β-farnesene Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Trans-β-farnesene Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Trans-β-farnesene Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Amyris Corporation Information
Table 54. Amyris Description and Major Businesses
Table 55. Amyris Product Models, Descriptions and Specifications
Table 56. Amyris Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Amyris Sales Value Proportion by Product in 2024
Table 58. Amyris Sales Value Proportion by Application in 2024
Table 59. Amyris Sales Value Proportion by Geographic Area in 2024
Table 60. Amyris Trans-β-farnesene SWOT Analysis
Table 61. Amyris Recent Developments
Table 62. Cayman Chemical Corporation Information
Table 63. Cayman Chemical Description and Major Businesses
Table 64. Cayman Chemical Product Models, Descriptions and Specifications
Table 65. Cayman Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Cayman Chemical Sales Value Proportion by Product in 2024
Table 67. Cayman Chemical Sales Value Proportion by Application in 2024
Table 68. Cayman Chemical Sales Value Proportion by Geographic Area in 2024
Table 69. Cayman Chemical Trans-β-farnesene SWOT Analysis
Table 70. Cayman Chemical Recent Developments
Table 71. Santa Cruz Biotechnology Corporation Information
Table 72. Santa Cruz Biotechnology Description and Major Businesses
Table 73. Santa Cruz Biotechnology Product Models, Descriptions and Specifications
Table 74. Santa Cruz Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Santa Cruz Biotechnology Sales Value Proportion by Product in 2024
Table 76. Santa Cruz Biotechnology Sales Value Proportion by Application in 2024
Table 77. Santa Cruz Biotechnology Sales Value Proportion by Geographic Area in 2024
Table 78. Santa Cruz Biotechnology Trans-β-farnesene SWOT Analysis
Table 79. Santa Cruz Biotechnology Recent Developments
Table 80. Hesheng Tech Corporation Information
Table 81. Hesheng Tech Description and Major Businesses
Table 82. Hesheng Tech Product Models, Descriptions and Specifications
Table 83. Hesheng Tech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Hesheng Tech Sales Value Proportion by Product in 2024
Table 85. Hesheng Tech Sales Value Proportion by Application in 2024
Table 86. Hesheng Tech Sales Value Proportion by Geographic Area in 2024
Table 87. Hesheng Tech Trans-β-farnesene SWOT Analysis
Table 88. Hesheng Tech Recent Developments
Table 89. Taskcm Corporation Information
Table 90. Taskcm Description and Major Businesses
Table 91. Taskcm Product Models, Descriptions and Specifications
Table 92. Taskcm Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Taskcm Sales Value Proportion by Product in 2024
Table 94. Taskcm Sales Value Proportion by Application in 2024
Table 95. Taskcm Sales Value Proportion by Geographic Area in 2024
Table 96. Taskcm Trans-β-farnesene SWOT Analysis
Table 97. Taskcm Recent Developments
Table 98. Key Raw Materials Distribution
Table 99. Raw Materials Key Suppliers
Table 100. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 101. Milestones in Production Technology Evolution
Table 102. Distributors List
Table 103. Market Trends and Market Evolution
Table 104. Market Drivers and Opportunities
Table 105. Market Challenges, Risks, and Restraints
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Trans-β-farnesene Product Picture
Figure 2. Global Trans-β-farnesene Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Anionic Pathways Product Picture
Figure 4. Cationic Pathways Product Picture
Figure 5. Global Trans-β-farnesene Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Polymers & Adhesives
Figure 7. Tires & LFR
Figure 8. Cosmetics
Figure 9. Others
Figure 10. Trans-β-farnesene Report Years Considered
Figure 11. Global Trans-β-farnesene Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 13. Global Trans-β-farnesene Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Trans-β-farnesene Revenue Market Share by Region (2020-2031)
Figure 15. Global Trans-β-farnesene Sales (2020-2031) & (Tons)
Figure 16. Global Trans-β-farnesene Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Trans-β-farnesene Sales Market Share by Region (2020-2031)
Figure 18. Global Trans-β-farnesene Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 19. Global Trans-β-farnesene Production Trend by Region (2020-2031) (Tons)
Figure 20. Global Trans-β-farnesene Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Trans-β-farnesene Production Growth Rate in North America (2020-2031) & (Tons)
Figure 23. Trans-β-farnesene Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 24. Trans-β-farnesene Production Growth Rate in China (2020-2031) & (Tons)
Figure 25. Trans-β-farnesene Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 26. Top 5 and Top 10 Manufacturers Trans-β-farnesene Sales Volume Market Share in 2024
Figure 27. Global Trans-β-farnesene Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Anionic Pathways Revenue Market Share by Manufacturer in 2024
Figure 30. Cationic Pathways Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Trans-β-farnesene Sales Market Share by Type (2020-2031)
Figure 34. Global Trans-β-farnesene Revenue Market Share by Type (2020-2031)
Figure 35. Global Trans-β-farnesene Sales Market Share by Application (2020-2031)
Figure 36. Global Trans-β-farnesene Revenue Market Share by Application (2020-2031)
Figure 37. North America Trans-β-farnesene Sales YoY (2020-2031) & (Tons)
Figure 38. North America Trans-β-farnesene Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Trans-β-farnesene Sales Revenue (US$ Million) in 2024
Figure 40. North America Trans-β-farnesene Sales Volume (Tons) by Type (2020- 2031)
Figure 41. North America Trans-β-farnesene Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Trans-β-farnesene Sales Volume (Tons) by Application (2020-2031)
Figure 43. North America Trans-β-farnesene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Trans-β-farnesene Sales YoY (2020-2031) & (Tons)
Figure 48. Europe Trans-β-farnesene Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Trans-β-farnesene Sales Revenue (US$ Million) in 2024
Figure 50. Europe Trans-β-farnesene Sales Volume (Tons) by Type (2020-2031)
Figure 51. Europe Trans-β-farnesene Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Trans-β-farnesene Sales Volume (Tons) by Application (2020-2031)
Figure 53. Europe Trans-β-farnesene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 55. France Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Trans-β-farnesene Sales YoY (2020-2031) & (Tons)
Figure 60. Asia-Pacific Trans-β-farnesene Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Trans-β-farnesene Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Trans-β-farnesene Sales Volume (Tons) by Type (2020- 2031)
Figure 63. Asia-Pacific Trans-β-farnesene Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Trans-β-farnesene Sales Volume (Tons) by Application (2020-2031)
Figure 65. Asia-Pacific Trans-β-farnesene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 70. India Trans-β-farnesene Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Trans-β-farnesene Sales YoY (2020-2031) & (Tons)
Figure 72. Central and South America Trans-β-farnesene Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Trans-β-farnesene Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Trans-β-farnesene Sales Volume (Tons) by Type (2021-2031)
Figure 75. Central and South America Trans-β-farnesene Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Trans-β-farnesene Sales Volume (Tons) by Application (2020-2031)
Figure 77. Central and South America Trans-β-farnesene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Trans-β-farnesene Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Trans-β-farnesene Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Trans-β-farnesene Sales YoY (2020-2031) & (Tons)
Figure 81. Middle East and Africa Trans-β-farnesene Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Trans-β-farnesene Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Trans-β-farnesene Sales Volume (Tons) by Type (2021-2031)
Figure 84. South America Trans-β-farnesene Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Trans-β-farnesene Sales Volume (Tons) by Application (2020-2031)
Figure 86. Middle East and Africa Trans-β-farnesene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Trans-β-farnesene Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Trans-β-farnesene Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Trans-β-farnesene Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Trans-β-farnesene Revenue (2020-2025) & (US$ Million)
Figure 91. Trans-β-farnesene Industry Chain Mapping
Figure 92. Regional Trans-β-farnesene Manufacturing Base Distribution (%)
Figure 93. Trans-β-farnesene Production Process
Figure 94. Regional Trans-β-farnesene Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Trans-β-farnesene market?
The top companies in the global Trans-β-farnesene market are Amyris、Cayman Chemical、Santa Cruz Biotechnology.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Trans-β-farnesene market size from 2025 to 2031?
What was the global market size of Trans-β-farnesene in 2025?
What was the global market size of Trans-β-farnesene in 2031?
Related Reports
Global Trans-β-farnesene Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Trans-β-farnesene market is projected to grow from US$ 79.08 million in 2025 to US$ 108 million by 2032, at a CAGR of 4.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 128
USD 4900.00
(Single User License)
Global Trans-β-farnesene Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Trans-β-farnesene market size was US$ 79.08 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of 4.7% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 65
USD 4250.00
(Single User License)
Trans-β-farnesene- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Trans-β-farnesene was estimated to be worth US$ 79.08 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 89
USD 3950.00
(Single User License)
Global Trans-β-farnesene Market Research Report 2026
The global Trans-β-farnesene market was valued at US$ 79.08 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 123
USD 2900.00
(Single User License)
Global Trans-β-farnesene Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Trans-β-farnesene market size was US$ 75.9 million in 2024 and is forecast to a readjusted size of US$ 104 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 70
USD 4250.00
(Single User License)
Trans-β-farnesene - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Trans-β-farnesene was estimated to be worth US$ 75.9 million in 2024 and is forecast to a readjusted size of US$ 104 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 83
USD 3950.00
(Single User License)
Global Trans-β-farnesene Market Research Report 2025
The global market for Trans-β-farnesene was valued at US$ 75.9 million in the year 2024 and is projected to reach a revised size of US$ 104 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published Date: 2025-03-10
Pages: 80
USD 2900.00
(Single User License)
Global Trans-β-farnesene Market Research Report 2024
Trans-β-farnesene is capable of being polymerized by both anionic and cationic pathways, creating low molecular weight polymers with structure–property relationships unique within the diene class of monomers. Trans-β-farnesene is produced through fermentation of sugar feedstocks. The pathway offers an alternative to petroleum-based feedstocks derived as by-products of naphtha or ethane cracking. Anionic polymerization of the monomer produces a highly branched “bottlebrush” structure, with rheological properties that are markedly different than those of linear diene polymers. Specifically, a lack of entanglements is observed even at relatively high molar masses. For hydroxyl-terminated oligomers, Tg as a function of molar mass follows a trend opposite non-functional materials.
Published Date: 2024-10-30
Pages: 79
USD 2900.00
(Single User License)
Global and United States Trans-β-farnesene Market Report & Forecast 2024-2030
Trans-β-farnesene is capable of being polymerized by both anionic and cationic pathways, creating low molecular weight polymers with structure–property relationships unique within the diene class of monomers. Trans-β-farnesene is produced through fermentation of sugar feedstocks. The pathway offers an alternative to petroleum-based feedstocks derived as by-products of naphtha or ethane cracking. Anionic polymerization of the monomer produces a highly branched “bottlebrush” structure, with rheological properties that are markedly different than those of linear diene polymers. Specifically, a lack of entanglements is observed even at relatively high molar masses. For hydroxyl-terminated oligomers, Tg as a function of molar mass follows a trend opposite non-functional materials.
Published Date: 2024-10-30
Pages: 100
USD 4350.00
(Single User License)
Global Trans-β-farnesene Market Insights, Forecast to 2030
Trans-β-farnesene is capable of being polymerized by both anionic and cationic pathways, creating low molecular weight polymers with structure–property relationships unique within the diene class of monomers. Trans-β-farnesene is produced through fermentation of sugar feedstocks. The pathway offers an alternative to petroleum-based feedstocks derived as by-products of naphtha or ethane cracking. Anionic polymerization of the monomer produces a highly branched “bottlebrush” structure, with rheological properties that are markedly different than those of linear diene polymers. Specifically, a lack of entanglements is observed even at relatively high molar masses. For hydroxyl-terminated oligomers, Tg as a function of molar mass follows a trend opposite non-functional materials.
Published Date: 2024-10-30
Pages: 117
USD 4900.00
(Single User License)
Global Trans-β-farnesene Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Trans-β-farnesene market is projected to grow from US$ 79.08 million in 2025 to US$ 108 million by 2032, at a CAGR of 4.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 128
USD 4900.00 (Single User License)Global Trans-β-farnesene Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Trans-β-farnesene market size was US$ 79.08 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of 4.7% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 65
USD 4250.00 (Single User License)Trans-β-farnesene- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Trans-β-farnesene was estimated to be worth US$ 79.08 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 89
USD 3950.00 (Single User License)Global Trans-β-farnesene Market Research Report 2026
The global Trans-β-farnesene market was valued at US$ 79.08 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 123
USD 2900.00 (Single User License)Global Trans-β-farnesene Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Trans-β-farnesene market size was US$ 75.9 million in 2024 and is forecast to a readjusted size of US$ 104 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 70
USD 4250.00 (Single User License)Trans-β-farnesene - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Trans-β-farnesene was estimated to be worth US$ 75.9 million in 2024 and is forecast to a readjusted size of US$ 104 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 83
USD 3950.00 (Single User License)Global Trans-β-farnesene Market Research Report 2025
The global market for Trans-β-farnesene was valued at US$ 75.9 million in the year 2024 and is projected to reach a revised size of US$ 104 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published: 2025-03-10
Pages: 80
USD 2900.00 (Single User License)Global Trans-β-farnesene Market Research Report 2024
Trans-β-farnesene is capable of being polymerized by both anionic and cationic pathways, creating low molecular weight polymers with structure–property relationships unique within the diene class of monomers. Trans-β-farnesene is produced through fermentation of sugar feedstocks. The pathway offers an alternative to petroleum-based feedstocks derived as by-products of naphtha or ethane cracking. Anionic polymerization of the monomer produces a highly branched “bottlebrush” structure, with rheological properties that are markedly different than those of linear diene polymers. Specifically, a lack of entanglements is observed even at relatively high molar masses. For hydroxyl-terminated oligomers, Tg as a function of molar mass follows a trend opposite non-functional materials.
Published: 2024-10-30
Pages: 79
USD 2900.00 (Single User License)Global and United States Trans-β-farnesene Market Report & Forecast 2024-2030
Trans-β-farnesene is capable of being polymerized by both anionic and cationic pathways, creating low molecular weight polymers with structure–property relationships unique within the diene class of monomers. Trans-β-farnesene is produced through fermentation of sugar feedstocks. The pathway offers an alternative to petroleum-based feedstocks derived as by-products of naphtha or ethane cracking. Anionic polymerization of the monomer produces a highly branched “bottlebrush” structure, with rheological properties that are markedly different than those of linear diene polymers. Specifically, a lack of entanglements is observed even at relatively high molar masses. For hydroxyl-terminated oligomers, Tg as a function of molar mass follows a trend opposite non-functional materials.
Published: 2024-10-30
Pages: 100
USD 4350.00 (Single User License)Global Trans-β-farnesene Market Insights, Forecast to 2030
Trans-β-farnesene is capable of being polymerized by both anionic and cationic pathways, creating low molecular weight polymers with structure–property relationships unique within the diene class of monomers. Trans-β-farnesene is produced through fermentation of sugar feedstocks. The pathway offers an alternative to petroleum-based feedstocks derived as by-products of naphtha or ethane cracking. Anionic polymerization of the monomer produces a highly branched “bottlebrush” structure, with rheological properties that are markedly different than those of linear diene polymers. Specifically, a lack of entanglements is observed even at relatively high molar masses. For hydroxyl-terminated oligomers, Tg as a function of molar mass follows a trend opposite non-functional materials.
Published: 2024-10-30
Pages: 117
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now